Skip to content
★ Sign in to follow
JL

Julia Le Blan

Board Director
The Biotech Growth Trust PLC
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€56k
▼ Sales (0 ops.)
—

Latest filing published 25 Apr 2018 for The Biotech Growth Trust PLC, €24k.

Filing timeline

BuySale
Julia Le Blan

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
100%
Median T+90
+8.9%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Julia Le Blan: trading record in brief

Julia Le Blan discloses dealings in The Biotech Growth Trust PLC to RNS (LSE). In total, 2 filings cover trades dated from 20 July 2016 to 18 April 2018.

No open-market sale appears; the market trades are 2 purchases worth €56k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2018, the count stands at 1 purchase and no sales.

The latest filing, published on 25 April 2018, reports an open-market purchase of €24k in The Biotech Growth Trust PLC. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Julia Le Blan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    Non-executive DirectorExecutivesThe Biotech Growth Trust PLC
    20,880 GBP11FCA-NSM
    3,000 shares@ £6.9642.8% of flowLondon Stock Exchange (XLON)ISIN GB0000385517FCA-NSM:PRNRNS_201804250945PR_NEWS_UKDISCLO_0088_20200330111352005_4306
    Canonical exit: 17 Jul 2018 (T+90)
  • ▲
    Non-executive DirectorExecutivesThe Biotech Growth Trust PLC
    26,600 GBP27FCA-NSM
    4,000 shares@ £6.65100.0% of flowLondon Stock Exchange (XLON)ISIN GB0000385517FCA-NSM:PRNRNS_201607201143PR_NEWS_UKDISCLO_0099_20200330143558513_15954
    Canonical exit: 18 Oct 2016 (T+90)

2 of 2 declarations